Managed Account Advisors’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

Managed Account Advisors’s Portfolio PTLA Stock Details PTLA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	$3.92M	Sell	86,077 -2,993	-3%	-$120K	﹤0.01%	1533
2015 Q1	$3.38M	Sell	89,070 -1,084	-1%	-$37.2K	﹤0.01%	1613
2014 Q4	$2.55M	Sell	90,154 -6,849	-7%	-$190K	﹤0.01%	1715
2014 Q3	$2.45M	Sell	97,003 -3,334	-3%	-$87.8K	﹤0.01%	1724
2014 Q2	$2.93M	Sell	100,337 -6,900	-6%	-$167K	﹤0.01%	1621
2014 Q1	$2.78M	Buy	107,237 +85,810	+400%	+$2.29M	﹤0.01%	1608
2013 Q4	$552K	Buy	21,427 +13,695	+177%	+$333K	﹤0.01%	2043
2013 Q3	$207K	Sell	7,732 -10,187	-57%	-$242K	﹤0.01%	2138
2013 Q2	$440K	Buy	+17,919	New	+$356K	﹤0.01%	2044

Other funds holding PTLA

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

EAM

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

MAM

MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return

Managed Account Advisors's PTLA Position: Q2 2015 in Review

Managed Account Advisors reduced its Portola Pharmaceuticals, Inc. (PTLA) stake by 3.4% in Q2 2015, selling an estimated $120K and leaving 86,077 shares worth $3.92M. The position accounts for ﹤0.01% of the portfolio, ranked #1533.

Managed Account Advisors first reported a position in PTLA in Q2 2013 and has held it in 9 quarters since. 160 funds tracked by Wall St. Rank hold PTLA as of Q2 2015.

Managed Account Advisors held 86,077 shares of Portola Pharmaceuticals, Inc. worth $3.92M as of Q2 2015.
Managed Account Advisors sold 2,993 Portola Pharmaceuticals, Inc. shares in Q2 2015, an estimated $120K.
Portola Pharmaceuticals, Inc. made up ﹤0.01% of Managed Account Advisors's portfolio in Q2 2015, its #1533 holding.
Managed Account Advisors first reported a position in Portola Pharmaceuticals, Inc. in Q2 2013 and has held it in 9 quarters since.
160 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q2 2015.

Based on Managed Account Advisors's 13F filing for Q2 2015, filed 14 Aug 2015.